Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Attenuated Inflammatory Response in Laparoscopic Colon Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01419431
Recruitment Status : Completed
First Posted : August 18, 2011
Last Update Posted : December 16, 2011
Sponsor:
Information provided by (Responsible Party):
Dag T Førland, Oslo University Hospital

Tracking Information
First Submitted Date July 18, 2011
First Posted Date August 18, 2011
Last Update Posted Date December 16, 2011
Study Start Date January 2007
Actual Primary Completion Date November 2011   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: August 17, 2011)
Inflammatory values for laparoscopic resection for colon cancer. [ Time Frame: 3 days ]
Corresponding values of SOCS3 mRNA copared to inflammatory cytokines in patients with laparoscopic resection for colon cancer.
Original Primary Outcome Measures Same as current
Change History Complete list of historical versions of study NCT01419431 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Attenuated Inflammatory Response in Laparoscopic Colon Surgery
Official Title Increased SOCS 3 mRNA in Monocytes From Patients Subjected to Laparoscopic Colon Surgery
Brief Summary Pro-inflammatory responses following laparoscopic surgery.
Detailed Description Blood samples from 20 patient with colon cancer collected before and in 3 days following laparoscopic surgery. Analyzed for inflammatory cytokines and corresponding SOCS3 mRNA.
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Colon cancer stage I-III
Condition Regulation of Inflammatory Response
Intervention Procedure: Laparoscopic resection
Inflammatory response in laparoscopic surgery
Other Name: Colon cancer
Study Groups/Cohorts Colon cancer patients
Laparoscopic resection
Intervention: Procedure: Laparoscopic resection
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Estimated Enrollment
 (submitted: August 17, 2011)
20
Original Estimated Enrollment Same as current
Actual Study Completion Date December 2011
Actual Primary Completion Date November 2011   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:Colon cancer stage I-III -

Exclusion Criteria:Colon cancer stage IV

-

Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Norway
Removed Location Countries  
 
Administrative Information
NCT Number NCT01419431
Other Study ID Numbers SOCS3 mRNA
SOCS-3-202008 ( Other Grant/Funding Number: OUS-SOCS3 )
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Dag T Førland, Oslo University Hospital
Study Sponsor Oslo University Hospital
Collaborators Not Provided
Investigators
Principal Investigator: Dag T. Førland, MD OUS
PRS Account Oslo University Hospital
Verification Date December 2011